N-(5-cycloheptyl-1H-pyrazol-3-yl)-3-methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide
C19H27N5O — CID 167960321
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(5-cycloheptyl-1H-pyrazol-3-yl)-3-methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide
N-(5-cycloheptyl-1H-pyrazol-3-yl)-3-methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide (PubChem CID 167960321) has the molecular formula C19H27N5O and a molecular weight of 341.46 g/mol. Its IUPAC name is N-(5-cycloheptyl-1H-pyrazol-3-yl)-3-methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide.
Molecular Properties
| Compound Name | N-(5-cycloheptyl-1H-pyrazol-3-yl)-3-methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide |
|---|---|
| PubChem CID | 167960321 |
| Molecular Formula | C19H27N5O |
| Molecular Weight | 341.46 g/mol |
| Exact Mass | 341.22 |
| IUPAC Name | N-(5-cycloheptyl-1H-pyrazol-3-yl)-3-methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide |
| SMILES | Cc1ncc2n1CCC(C(=O)Nc1cc(C3CCCCCC3)[nH]n1)C2 |
| InChI | InChI=1S/C19H27N5O/c1-13-20-12-16-10-15(8-9-24(13)16)19(25)21-18-11-17(22-23-18)14-6-4-2-3-5-7-14/h11-12,14-15H,2-10H2,1H3,(H2,21,22,23,25) |
| InChIKey | BHLPMWKSENPBFB-UHFFFAOYSA-N |
| XLogP | 3.55 |
| TPSA | 75.60 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 341.46 |
| LogP ≤ 5 | 3.55 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167960321 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.